Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.58 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | GPR183 | P32249 | 5/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16598709 | 0.93 | KMT2A (0.62) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL17954151 | 0.90 | HRH4 (0.63) | KMT2AMEN1HRH4GPR183AKR1C3 | |
| SCHEMBL16599031 | 0.90 | GPR183 (0.66) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL17954142 | 0.88 | KMT2A (0.60) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL17954139 | 0.84 | GPR183 (0.64) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL17954140 | 0.83 | KMT2A (0.73) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL16598882 | 0.82 | GPR183 (0.71) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL16599485 | 0.81 | GPR183 (0.82) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL16598942 | 0.81 | AKR1C3 (0.69) | KMT2AMEN1HRH4HRH3HRH1 | |
| SCHEMBL17938686 | 0.81 | GPR183 (0.80) | KMT2AMEN1HRH4HRH3HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9776979-B2 | EBI2 modulators | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2017-10-03 | — | — | US | disclosed |
| US-20160214951-A1 | EBI2 MODULATORS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160214951-A1 | EBI2 MODULATORS | BIRC2, HAVCR2, MAVS | KMT2A 1057/4885MEN1 2201/4885HRH4 3590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.